Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational study

Marc Ferrante, Anja Schirbel, Marieke J Pierik, Thomas Haas, Mathurin Flamant, Ahmed Khalifa, George Philip, Freddy Cornillie, Alan G Meehan, Marinella Govoni

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)646-654
Number of pages9
JournalEuropean Journal of Gastroenterology & Hepatology
Volume34
Issue number6
Early online date8 Apr 2022
DOIs
Publication statusPublished - Jun 2022

Keywords

  • Mayo score
  • REMISSION
  • golimumab
  • moderate-to
  • severe ulcerative colitis

Cite this